Kong, L., Wang, L., Xing, L., & Yu, J. (2017). Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases. KeAi Communications Co., Ltd.
Style de citation Chicago (17e éd.)Kong, Ling-Ling, Lin-Lin Wang, Li-Gang Xing, et Jin-Ming Yu. Current Progress and Outcomes of Clinical Trials on Using Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor Therapy in Non-small Cell Lung Cancer Patients with Brain Metastases. KeAi Communications Co., Ltd, 2017.
Style de citation MLA (8e éd.)Kong, Ling-Ling, et al. Current Progress and Outcomes of Clinical Trials on Using Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor Therapy in Non-small Cell Lung Cancer Patients with Brain Metastases. KeAi Communications Co., Ltd, 2017.